About Martin
I have an MSc in Industrial Engineering, and an MPH / MBA from the University of Oxford. I started my career in management consulting at a former McKinsey-led firm in Latin America. I have built and led international commercial teams at the intersection of complex science, market access, and commercial execution in the life sciences industry. At Johnson & Johnson, I created the first UK Precision Medicine Commercial Organisation (marketing & sales) from scratch and led national NHS negotiations to embed biomarkers into clinical pathways. I previously built EMEA launch excellence, lifecycle management and portfolio strategies deployed across 20+ international markets. I combined hands-on brand strategy leadership and matrix execution with deep experience across different therapeutic areas. I have owned Oncology/Haematology P&Ls to drive organic growth, and I have led CNS, ID and Vaccines in-licenses & acquisitions, fostering inorganic growth through deal-making. I am particularly well-suited for a healthcare leadership role to shape brand strategy, ensure consistent regional execution and drive performance across diverse markets.
Italian
Native or bilingual
Spanish
Native or bilingual
English
Native or bilingual
Can work on-site
London (up to 50km)
Experience
- Johnson & JohnsonUK Commercial Head of Precision MedicinePHARMACEUTICALS INDUSTRYJanuary 2024 - February 2026 (2 years and 2 months)London, UK• • Led marketing / commercial activities for 3 Oncology / Haematology drugs with £800MM 5-yr projected UK sales & co-developing early pipeline testing strategy (Rare Diseases, CNS)• • Established J&J UK's first Precision Medicine Commercial team, building operational capabilities, leading field force and deploying a new GTM model to for personalized drugs• • Owned negotiations with NHS genomics to include 3 biomarkers in the Test Directory, driving NGS testing rates in the genitourinary space from 20% to over 40% in 20 targeted accounts
- Johnson & JohnsonNew Business Development Sr. Manager (EMEA / LATAM)PHARMACEUTICALS INDUSTRYAugust 2022 - January 2024 (1 year and 5 months)London, United Kingdom• • Led portfolio partnerships and operating model design across LATAM to commercialize J&J's mature portfolio, reducing OPEX ratio from 8% to 2.5% (~ $5Mn annual revenue increase)• • Led in-licensing and integration of Nanomedicine Oncology asset ($ 2.3Bn PYS), successfully reclassifying it from Medical Device to Drug and achieving commercial synergies• • Co-led commercial due diligence for an ~ $12Bn acquisition deal in the CNS space, shaping portfolio strategy, investment thesis, OPEX allocation and multi-market adoption forecasts
- Johnson & JohnsonStrategy Program Manager – IRDP Leadership PathPHARMACEUTICALS INDUSTRYJanuary 2021 - August 2022 (1 year and 7 months)London, United Kingdom• • Co-chaired Janssen ESO largest change management program ($48.1 Mn OPEX investment) to maximize value and competitiveness of new assets through their lifecycle• • Built first EMEA Launch Excellence & Lifecycle Management team with $5.7 Bn AUM, designing a new 10-years Brand Strategy & Business Plan implemented in +20 countries• • Designed first Integrated Digital & Analytics Plan (IDAP) for the region, including a budget & FTE data-collection tool to drive customer engagement at scale (30 big ticket items approved)
Recommendations
Be the first to recommend Martin
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- Postgraduate Education ProgramUniversity of Oxford2026Private Equity in Healthcare
- Postgraduate Education ProgramColumbia Business School2022Postgraduate Education Program
Certifications
- Technology AI Advanced Coding & Workflow AutomationAnthropic2026